{"changes":[],"country":"ES","description":"aptaTargets is a clinical-stage biopharmaceutical developing aptamer-based therapeutics targeting acute inflammatory conditions like ischemic stroke. It serves patients suffering from stroke, intracerebral hemorrhage, myocardial infarction, and multiple sclerosis. Its lead candidate ApTOLL is the only drug in development that treats stroke by blocking TLR4 activation, a neuroprotective mechanism now licensed to Merck.","domain":"aptatargets.com","employees":null,"founded":2014,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech","investors":[],"lat":40.416782,"lng":-3.703507,"location":"Madrid, Spain","name":"AptaTargets","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2024-04-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"aptatargets-com","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"aptatargets.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://aptatargets.com"},{"fact":"description","publisher":"aptatargets.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://aptatargets.com"}],"stage":null,"techStack":["Nginx 1.29.2","Yoast SEO 13.2","Google Analytics","Google Tag Manager","Slider Revolution","jQuery Migrate 1.4.1","DoubleClick Floodlight","React","PHP","MySQL","wordpress .","jquery 1.1"],"totalRaisedUsd":7000000,"updatedAt":"2026-05-02"}